Healthcare Industry News: Mylan Laboratories
News Release - October 1, 2007
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information OfficerPITTSBURGH, Pa., Oct. 1 (HSMN NewsFeed) -- Mylan Laboratories Inc. (NYSE: MYL ) today announced the appointment of Gregory L. Sheldon as Global Chief Information Officer (CIO), effective October 15, 2007. Mr. Sheldon brings over 25 years of experience in developing and executing information technology strategy, systems and processes in the pharmaceutical, consumer products, and business services industries.
Mr. Sheldon has held numerous leadership positions, most recently as the Vice President of Global Program Delivery and Engineering at Pfizer, Inc. As the chief engineer and global leader of information technology (IT) program delivery, Mr. Sheldon built and led efforts responsible for the transformation of separate corporate technology platforms into a unified global infrastructure. Prior to Pfizer, Mr. Sheldon held executive positions with Choice Point Services Company, Georgia-Pacific Corporation, the Georgia Lottery Corporation and Kraft Foods.
Mr. Sheldon has extensive experience with the design and deployment of company-wide networks and business systems, the integration of separate IT infrastructures, and supportive business functions such as regulatory and Sarbanes-Oxley compliance. His professional background also encompasses distributed systems management and leadership development.
Mylan Vice Chairman and CEO Robert J. Coury commented: "We have been clearly focused on building our senior leadership with the best and the brightest in the industry. It is therefore my pleasure to welcome Greg to the Mylan family. Through years of significant experience, he has built an expertise in the leadership of key information technology strategies that have positively impacted the businesses where he has been employed. Having had the opportunity to navigate the complexity of the pharmaceutical industry as well as engineering international functions, Greg is well-suited to create and execute a global vision for the technical infrastructure needed to enhance Mylan's growing operations throughout the world."
Greg holds a master's of science in management from Georgia State University and a bachelor's of science degree in industrial management from the Georgia Institute of Technology.
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, please visit www.mylan.com.
Source: Mylan Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.